GUARDANT HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.35 USD | +1.11% |
|
+7.97% | -35.86% |
| Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
| Apr. 22 | Sector Update: Health Care Stocks Rise in Monday Afternoon Trading | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,338 | 12,884 | 10,168 | 2,786 | 3,283 | 2,115 | - | - |
| Enterprise Value (EV) 1 | 7,338 | 11,896 | 10,370 | 2,912 | 3,255 | 2,407 | 2,566 | 2,788 |
| P/E ratio | -93 x | -49.6 x | -25 x | -4.24 x | -6.32 x | -5.17 x | -5.75 x | -6.45 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 34.2 x | 44.9 x | 27.2 x | 6.2 x | 5.82 x | 3.19 x | 2.63 x | 2.11 x |
| EV / Revenue | 34.2 x | 41.5 x | 27.8 x | 6.48 x | 5.77 x | 3.63 x | 3.2 x | 2.79 x |
| EV / EBITDA | -103 x | -140 x | -26.7 x | -5.84 x | -7.46 x | -7.16 x | -9.06 x | -10.2 x |
| EV / FCF | -111 x | -84.9 x | -36.5 x | -7.53 x | -9.42 x | -7.56 x | -9.37 x | -13.2 x |
| FCF Yield | -0.9% | -1.18% | -2.74% | -13.3% | -10.6% | -13.2% | -10.7% | -7.6% |
| Price to Book | 9.23 x | 9.95 x | 15.8 x | 46.4 x | 20.7 x | -17.1 x | -6.94 x | -4.4 x |
| Nbr of stocks (in thousands) | 93,906 | 99,972 | 101,656 | 102,436 | 121,380 | 121,885 | - | - |
| Reference price 2 | 78.14 | 128.9 | 100.0 | 27.20 | 27.05 | 17.35 | 17.35 | 17.35 |
| Announcement Date | 2/24/20 | 2/24/21 | 2/23/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 214.4 | 286.7 | 373.7 | 449.5 | 563.9 | 663.7 | 802.6 | 1,001 |
| EBITDA 1 | -70.96 | -85.18 | -388.7 | -498.9 | -436.3 | -336.2 | -283.3 | -273.5 |
| EBIT 1 | -82.37 | -255 | -411 | -544.4 | -564.7 | -403.8 | -362.7 | -296.1 |
| Operating Margin | -38.42% | -88.92% | -110% | -121.1% | -100.14% | -60.84% | -45.19% | -29.58% |
| Earnings before Tax (EBT) 1 | -69.72 | -245.9 | -384.5 | -653.4 | -478.8 | -398.9 | -365 | -299.7 |
| Net income 1 | -75.65 | -253.8 | -405.7 | -654.6 | -479.4 | -398.5 | -363.7 | -332.6 |
| Net margin | -35.29% | -88.51% | -108.57% | -145.61% | -85.02% | -60.04% | -45.31% | -33.23% |
| EPS 2 | -0.8400 | -2.600 | -4.000 | -6.410 | -4.280 | -3.355 | -3.016 | -2.688 |
| Free Cash Flow 1 | -65.85 | -140.1 | -284.1 | -386.9 | -345.5 | -318.2 | -273.8 | -211.9 |
| FCF margin | -30.72% | -48.86% | -76.02% | -86.07% | -61.26% | -47.93% | -34.11% | -21.17% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/20 | 2/24/21 | 2/23/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 94.78 | 108.1 | 96.1 | 109.1 | 117.4 | 126.9 | 128.7 | 137.2 | 143 | 155.1 | 150.1 | 160.8 | 168 | 183.7 | 182 |
| EBITDA 1 | -101.7 | -92.12 | -111.6 | -120 | -122.6 | -133.3 | -123.4 | -108.1 | -101.8 | -102.9 | -89.68 | -103.2 | -85.53 | -81.72 | -86 |
| EBIT 1 | -107.3 | -98.21 | -123.3 | -130.3 | -144.6 | -146.1 | -134.1 | -119.6 | -113.5 | -197.5 | -108.4 | -104.7 | -100.3 | -95.62 | -101.7 |
| Operating Margin | -113.2% | -90.84% | -128.34% | -119.4% | -123.16% | -115.15% | -104.15% | -87.22% | -79.38% | -127.38% | -72.25% | -65.1% | -59.66% | -52.06% | -55.87% |
| Earnings before Tax (EBT) 1 | -107.4 | -72.3 | -123.3 | -229 | -161.9 | -139.3 | -133.3 | -72.28 | -85.61 | -187.6 | -106.8 | -105.5 | -102.9 | -99.01 | -107.1 |
| Net income 1 | -107.5 | -90.91 | -123.2 | -229.4 | -162 | -139.9 | -133.5 | -72.77 | -86.1 | -187 | -107.3 | -102.9 | -100.4 | -96.76 | -101.5 |
| Net margin | -113.45% | -84.09% | -128.23% | -210.21% | -137.98% | -110.28% | -103.74% | -53.06% | -60.2% | -120.63% | -71.52% | -64.02% | -59.74% | -52.68% | -55.74% |
| EPS 2 | -1.060 | -0.8900 | -1.210 | -2.250 | -1.580 | -1.360 | -1.300 | -0.6700 | -0.7300 | -1.580 | -0.9001 | -0.8614 | -0.8385 | -0.8055 | -0.8451 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/23/22 | 5/5/22 | 8/4/22 | 11/3/22 | 2/23/23 | 5/9/23 | 8/3/23 | 11/6/23 | 2/22/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 202 | 126 | - | 292 | 451 | 673 |
| Net Cash position 1 | - | 989 | - | - | 28.7 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | -0.5198 x | -0.2529 x | - | -0.8689 x | -1.593 x | -2.461 x |
| Free Cash Flow 1 | -65.9 | -140 | -284 | -387 | -345 | -318 | -274 | -212 |
| ROE (net income / shareholders' equity) | -11.8% | -24.2% | -41.7% | -186% | -438% | -385% | -52.3% | -41.3% |
| ROA (Net income/ Total Assets) | -9.76% | -15.7% | -18.1% | -34.3% | -28.2% | -17.4% | -17.6% | -13.8% |
| Assets 1 | 775 | 1,617 | 2,238 | 1,907 | 1,698 | 2,292 | 2,065 | 2,405 |
| Book Value Per Share 2 | 8.470 | 13.00 | 6.340 | 0.5900 | 1.300 | -1.010 | -2.500 | -3.940 |
| Cash Flow per Share 2 | -0.5200 | -1.070 | -2.060 | -3.030 | -2.900 | -2.300 | -1.210 | 0.4400 |
| Capex 1 | 18.7 | 36.2 | 75 | 77.5 | 20.5 | 48.7 | 56.1 | 67 |
| Capex / Sales | 8.73% | 12.62% | 20.08% | 17.23% | 3.63% | 7.34% | 6.99% | 6.69% |
| Announcement Date | 2/24/20 | 2/24/21 | 2/23/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
17.35
USD
Average target price
39.41
USD
Spread / Average Target
+127.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -35.86% | 2.11B | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M | |
| +13.32% | 332M |
- Stock Market
- Equities
- GH Stock
- Financials Guardant Health, Inc.
